Liver cell transformation in chronic HBV infection
- PMID: 21994562
- PMCID: PMC3185520
- DOI: 10.3390/v1030630
Liver cell transformation in chronic HBV infection
Abstract
Epidemiological studies have provided overwhelming evidence for a causal role of chronic HBV infection in the development of hepatocellular carcinoma (HCC), but the molecular mechanisms underlying virally-induced tumorigenesis remain largely debated. In the absence of a dominant oncogene encoded by the HBV genome, indirect roles have been proposed, including insertional activation of cellular oncogenes by HBV DNA integration, induction of genetic instability by viral integration or by the regulatory protein HBx, and long term effects of viral proteins in enhancing immune-mediated liver disease. In this chapter, we discuss different models of HBV-mediated liver cell transformation based on animal systems of hepadnavirus infection as well as functional studies in hepatocyte and hepatoma cell lines. These studies might help identifying the cellular effectors connecting HBV infection and liver cell transformation.
Keywords: HBx; hepatitis B virus; hepatocellular carcinoma; pathogenesis; transformation.
Figures


Similar articles
-
Mechanisms of HBV-related hepatocarcinogenesis.J Hepatol. 2010 Apr;52(4):594-604. doi: 10.1016/j.jhep.2009.10.033. Epub 2010 Jan 7. J Hepatol. 2010. PMID: 20185200 Review.
-
Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinoma.Annu Rev Med. 1994;45:297-323. doi: 10.1146/annurev.med.45.1.297. Annu Rev Med. 1994. PMID: 8198385 Review.
-
Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma.J Med Virol. 1990 May;31(1):18-32. doi: 10.1002/jmv.1890310106. J Med Virol. 1990. PMID: 2165515 Review.
-
Mechanisms of HBV-induced hepatocellular carcinoma.J Hepatol. 2016 Apr;64(1 Suppl):S84-S101. doi: 10.1016/j.jhep.2016.02.021. J Hepatol. 2016. PMID: 27084040 Review.
-
Hepatitis B virus infection and the risk of hepatocellular carcinoma.World J Gastroenterol. 2011 Nov 28;17(44):4853-7. doi: 10.3748/wjg.v17.i44.4853. World J Gastroenterol. 2011. PMID: 22171125 Free PMC article. Review.
Cited by
-
Dynamic Changes in Serum Markers and Their Utility in the Early Diagnosis of All Stages of Hepatitis B-Associated Hepatocellular Carcinoma.Onco Targets Ther. 2020 Jan 28;13:827-840. doi: 10.2147/OTT.S229835. eCollection 2020. Onco Targets Ther. 2020. PMID: 32095079 Free PMC article.
-
The Woodchuck, a Nonprimate Model for Immunopathogenesis and Therapeutic Immunomodulation in Chronic Hepatitis B Virus Infection.Cold Spring Harb Perspect Med. 2015 Oct 28;5(12):a021451. doi: 10.1101/cshperspect.a021451. Cold Spring Harb Perspect Med. 2015. PMID: 26511761 Free PMC article. Review.
-
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.Oncotarget. 2016 Jan 5;7(1):473-89. doi: 10.18632/oncotarget.6337. Oncotarget. 2016. PMID: 26595522 Free PMC article.
References
-
- Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis. 2000;21:405–426. - PubMed
-
- Pagano JS, Blaser M, Buendia MA, Damania B, Khalili K, Raab-Traub N, Roizman B. Infectious agents and cancer: criteria for a causal relation. Semin Cancer Biol. 2004;14:453–471. - PubMed
-
- Szmuness W. Hepatocellular carcinoma and the hepatitis B virus : Evidence for a causal association. Prog Med Virol. 1978;24:40–69. - PubMed
-
- Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006;118:3030–3044. - PubMed
-
- Paterlini P, Driss F, Pisi E, Franco D, Berthelot P, Bréchot C. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg negative patients: a study of a low endemic area. Hepatology. 1993;17:20–29. - PubMed
LinkOut - more resources
Full Text Sources